- Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). Hanna, M.G., Stewart, J., Schapira, A.H., Wood, N.W., Morgan-Hughes, J.A., Murray, N.M. J. Neurol. Neurosurg. Psychiatr. (1998)